Trials
Finished studies
Read about our projects
-
A Randomized phase III trial of six cycles of docetaxel versus surveillance plus hormonal treatment after radical radiotherapy in patients with intermediate or high-risk prostate cancer (SPCG-13 AdRad)
See details -
An open randomised phase III trial of six cycles of docetaxel versus surveillance after radical prostatectomy in prostate cancer patients with high grade pT3 or margin positive pT2
See details -
Randomised trial comparing radical prostatectomy versus radiotherapy plus protocol on follow-up of non-randomised patients with localised prostate cancer
See details -
Antiandrogen followed by TAB on biochemical progression versus TAB
See details -
An open pilot study evaluating intermittent androgen suppression in patients with advanced prostate cancer
See details -
Institution of second-line Estracyt therapy at an increase in PSA values for metastatic prostate cancer
See details -
Post-treatment Prostatic Biopsies after Antiandrogen treatment with or without Radiotherapy
See details -
Randomized trial of locally advanced prostate cancer. Antiandrogen treatment with or without radiotherapy
See details -
A randomized, double-blind, parallel-group trial comparing Casodex 150 mg once daily with placebo in patients with non-metastatic prostate cancer
See details